Background/aim: Recently, we reported a myoid hamartoma carrying a t(5;12)(p13;q14) karyotypic aberration leading to fusion of the high-mobility group AT-hook 2 (HMGA2) gene with a sequence from chromosome sub-band 5p13.2. We describe here another benign myoid tumor of the breast with identical genetic aberrations.
Materials and methods: A mammary leiomyomatous tumor found in a 45-year-old woman was studied using cytogenetics, fluorescence in situ hybridization, RNA sequencing, reverse transcription-polymerase chain reaction and Sanger sequencing.
Results: The karyotype of the tumor cells was 46,XX,t(5;12) (p13;q14). Fluorescence in situ hybridization showed rearrangement of HMGA2, RNA sequencing detected fusion of HMGA2 with a sequence from 5p13.2, whereupon reverse transcription-polymerase chain reaction together with Sanger sequencing verified the HMGA2-fusion transcript. The results were identical to those obtained by us previously in a myoid hamartoma of the breast.
Conclusion: The translocation t(5;12)(p13;q14) and fusion of HMGA2 with sequences from sub-band 5p13.2 appear to be recurrent events in benign mammary myoid neoplasms.
Keywords: HMGA2 rearrangement; Myoid hamartoma of the breast; chromosomal translocation t(5;12)(p13;q14); chromosome sub-band 5p13.2; intergenic sequence; leiomyoma; myoid neoplasm.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.